Plus, news about Astellas, Clover, ElevateBio, Monopar, Idorsia and Neurocrine Biosciences:
Vera Therapeutics plans $300M offering: The California biotech is
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.